Caspase- and serine protease-dependent apoptosis by the death domain of FADD in normal epithelial cells

被引:34
作者
Thorburn, J
Bender, LM
Morgan, MJ
Thorburn, A [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA
关键词
D O I
10.1091/mbc.E02-04-0207
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The adapter protein FADD consists of two protein interaction domains: a death domain and a death effector domain. The death domain binds to activated death receptors such as Fas, whereas the death effector domain binds to procaspase 8. An FADD mutant, which consists of only the death domain (FADD-DD), inhibits death receptor-induced apoptosis. FADD-DD can also activate a mechanistically distinct, cell type-specific apoptotic pathway that kills normal but not cancerous prostate epithelial cells. Here, we show that this apoptosis occurs through activation of caspases 9, 3, 6, and 7 and a serine protease. Simultaneous inhibition of caspases and serine proteases prevents FADD-DD-induced death. Inhibition of either pathway alone does not prevent cell death but does affect the morphology of the dying cells. Normal prostate epithelial cells require both the caspase and serine protease inhibitors to efficiently prevent apoptosis in response to TRAIL. In contrast, the serine protease inhibitor does not affect TRAIL-induced death in prostate tumor cells suggesting that the FADD-DD-dependent pathway can be activated by TRAIL. This apoptosis pathway is activated in a cell type-specific manner that is defective in cancer cells, suggesting that this pathway may be targeted during cancer development.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 49 条
[1]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[2]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[3]   In situ monitoring of caspase activation in hepatobiliary diseases [J].
Bantel, H ;
Ruck, P ;
Schulze-Osthoff, K .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (05) :504-505
[4]   Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis [J].
Caulin, C ;
Salvesen, GS ;
Oshima, RG .
JOURNAL OF CELL BIOLOGY, 1997, 138 (06) :1379-1394
[5]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[6]   Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I [J].
Coleman, ML ;
Sahai, EA ;
Yeo, M ;
Bosch, M ;
Dewar, A ;
Olson, MF .
NATURE CELL BIOLOGY, 2001, 3 (04) :339-345
[7]   Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria [J].
Denecker, G ;
Vercammen, D ;
Steemans, M ;
Vanden Berghe, T ;
Brouckaert, G ;
Van Loo, G ;
Zhivotovsky, B ;
Fiers, W ;
Grooten, J ;
Declercq, W ;
Vandenabeele, P .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (08) :829-840
[8]   Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition [J].
Du, CY ;
Fang, M ;
Li, YC ;
Li, L ;
Wang, XD .
CELL, 2000, 102 (01) :33-42
[9]   The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program [J].
Elliott, K ;
Ge, K ;
Du, W ;
Prendergast, GC .
ONCOGENE, 2000, 19 (41) :4669-4684
[10]   Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor [J].
Foghsgaard, L ;
Wissing, D ;
Mauch, D ;
Lademann, U ;
Bastholm, L ;
Boes, M ;
Elling, F ;
Leist, M ;
Jäättelä, M .
JOURNAL OF CELL BIOLOGY, 2001, 153 (05) :999-1009